[S-17] To pursue the best treatment of MG

[S-17-1] The treatment strategies of Japanese clinical guidelines for myasthenia gravis

^○Hiroyuki Murai (Department of Neurology, International University of Health and Welfare, Japan)

Prof. Murai graduated from Kyushu University, Japan in 1988 and was trained as a neurologist thereafter. From 1995 to 1998, he was affiliated with Roswell Park Cancer Institute, Buffalo, NY, as a Neurology follow. From 2000, he has served as an assistant professor at Department of Neurology, Kyushu University. He was nominated as a professor and chairman of Department of Neurology, School of Medicine, International University of Health and Welfare, a newly established medical school in Narita, in 2017.
He has devoted his career to studying myasthenia gravis (MG). His doctoral thesis was about immunohistological study of thymus in MG. He performed nationwide epidemiological survey of MG in Japan in 2006. He is an executive member of Japan MG Registry Study Group. He also served as a member of Japanese Committee on the Clinical Guidelines for MG. Internationally, he served as a member of MGFA Task Force on International MG Treatment Guidelines.